
A study found that designating a Pediatric Emergency Care Coordinator significantly boosts EMS readiness, care coordination, and safety for young patients.

A study found that designating a Pediatric Emergency Care Coordinator significantly boosts EMS readiness, care coordination, and safety for young patients.

A study found no significant difference in increased intracranial pressure risk between surgical and conservative management for children with metopic synostosis.

The expanded approval provides young pediatric patients with a proven, effective treatment to significantly reduce dangerously high LDL-C levels.

The approval offers a new genotype-independent treatment option for patients aged 12 years and older, significantly reducing blood phenylalanine levels.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

The FDA has approved once-weekly somapacitan-beco for children aged 2.5 years and older with 3 separate growth indications.

A study found that hepatitis B virus birth dose vaccination rates fell from 83.5% in early 2023 to 73.2% by August 2025.

The FDA has approved desmopressin acetate, the first formulation designed for individualized dosing in patients with central diabetes insipidus.

The approval marks the first FDA-authorized treatment for allergic fungal rhinosinusitis, with trial data showing significant improvements in outcome measures.

A study found cannabis use among adolescents aged 13 to 17 years was associated with a 2-fold increased risk of psychotic and bipolar disorders.

A study highlights prior self-harm, traumatic brain injury, family instability, and social vulnerability as major risk factors associated with suicide among Black youth.

The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Children with Crohn disease had reduced microbial diversity and increased pro-inflammatory bacteria vs peers with disorders of brain-gut interaction.

A study found that pediatric patients meeting burn center referral criteria were more likely to receive specialized care.

Findings demonstrate high completion rates and overall acceptability of the EQ-5D-Y-5L in routine outpatient pediatric specialty care.

Trial data indicate that clesrovimab has a safety profile comparable to palivizumab and maintained protection against RSV-related infections.

A national poll finds few parents have their teens evaluated for heart disease, while gaps in training highlight ongoing challenges in responding to sudden cardiac arrest.

A study found that 30 mg/kg/d methylprednisolone combined with tocilizumab was linked to improved neurological outcomes for encephalopathy.